华尔街俱乐部中概股个股报价资讯

17.36 USD -0.32 -1.81%

OPEN

17.43

PREV CLOSE

17.68

VOLUME

26,041

MARKET CAP

3.026B

DAY RANGE

17.27 - 17.60

52 WEEK RANGE

11.93 - 21.92

About HUTCHMED China Ltd

HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.

SECTOR

Health Care

INDUSTRY

Health Care

SUB-INDUSTRY

Biotech & Pharma

ADDRESS

Level 18, The Metropolis Tower 10 Metropolis Drive Kowloon Hong Kong (SAR)

PHONE

852-2128-1188

WEBSITE

www.hutch-med.com

Key Statistics

P/E Ratio

-0.17

1 Year Return

-9.82

Estimated P/E

3.00

30 Day Avg Volume

Price/Book (mrq)

4.10

Dividend

Last Dividend Reported

Executives

Dr Wei-Guo Su PhD / CEO/Chief Scientific Officer/Executive Director
Cheng Chig Fung "Johnny" / CFO/Executive Director
Dr Junjie Zhou / President:Shanghai Hutchison Pharmaceuticals
Dr Karen Jane Atkin / Exec VP/COO
Dr Shi Ming "Michael" / Exec VP/Chief Medical Officer/Head:R&D
Dr Zhenping Wu / Exec VP:Pharmaceutical Science & Manufacturing
Hong Chen / Senior VP/Chief Commercial Ofcr:China
Yiling Cui / Senior VP:Government Affairs
Dr Thomas Fu / Senior VP:Global Quality
Kin Hung Lee "Mark" / Senior VP:Corporate Finance & Dev/IR
Dr May Qingmei Wang / Senior VP:Bus Dev & Strategic Alliances
Selina Zhang / Senior VP:Global Human Resources
Michael Leung / VP:Corporate Operations
Edith Shih / Secretary
Charles George Rupert Nixon / General Counsel
David Ng / Head:Investor Relations & Capital Strategies

华尔街俱乐部资本市场资讯服务